29K iOS Apps Tracked Updated 4 min ago Revenue Forecasts
Add an app Create Account Sign In
Home

Glykämischer Index. Diabetes.

63
Quality Score
Solid

Glykämischer Index. Diabetes.

Medium confidence
4.5 ✍️ Editor
✍️ bumetric analysis

Glykämischer Index. Diabetes. is an iOS app from App Holdings in the Education category, currently rated 4.5★ across 3,470 ratings. Initial signal reads as mostly critical sentiment so far: users flag rough edges and unmet expectations.

Quality Score is 63: Solid (established niche player). For a Education app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.

Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.

💰 Monthly revenue · now vs forecast
● Right now
$5.0K
per month
12-mo forecast
$5.2K – $10.8K
per month
24-mo forecast
$6.4K – $19.2K
per month
MID tier
💡 Grow this revenue
Free AI audit of this app’s store listing
  • Title & subtitle keyword fit
  • Description hook & conversion structure
  • Screenshots, ratings, reviews strategy
Run free AI audit →
Typical impact: +2-5× organic installs
🔔Notify me when this app's revenue changes by

📊 Performance Tracking LIVE

Loading…
idle
0%
Rating
Reviews
Forecast Revenue / mo
Snapshots tracked
0
since first record
ONE-TIME · BUILD 💰 Estimated build cost
$60K
What it cost to build · not monthly revenue
Likely range $45K – $80K
$25K · MVP floor $100K · indie scale $500K+ · studio build
📈 Slow ROI — current MRR is well below build cost

Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.

Where the money goes
🧱 MVP baseline (design + 1-store ship) +$28K
📱 5 unique screens × $4.5K +$22K
Education complexity ×1.20 +$10K
Total estimate $60K
👥 Estimated audience size
290K
Lifetime downloads (US-equivalent)
Monthly active
52K
Daily active
15K

Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.

How we sized it
📲 Education engagement ~85 installs / rating
🔁 Education D30 retention 18%
📍 DAU / MAU stickiness 0.30
DAU / MAU 30% sticky
🔬

How we forecast this revenue

MEDIUM CONFIDENCE
Baseline
$5.0K/mo · ML-estimated from 234 triggers
Growth rate
+4.0% MoM · MID tier baseline (compound monthly)
6 months
$4.7K – $7.9K
12 months
$5.2K – $10.8K
24 months
$6.4K – $19.2K
Compound growth at +4.0% MoM (tier baseline for MID). Range widens with horizon — typical noise band ±25% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊

BU Investment Matrix

Below median · 54/100MID TIERunderperforming peers
GrowthFounderQualityRevenueMonetiz.MoatMarketSafety
Growth Velocity
5.0
Founder Strength
7.4
Product Quality
8.2
Revenue Strength
3.7
Monetization Maturity
1.0
Defensibility
7.5
Market Position
0.3
Operational Safety
10.0
  • 💰 Revenue: Modest — $3K - $7K/mo · MID tier · medium confidence, trajectory unclear.
  • ⭐ Quality: 4.53★ across 3,470 reviews — strong (top 10%).
  • 📍 Market: Not yet charting in any of the 9 monitored markets.
  • 📈 Growth: Insufficient signal to assess trajectory.
  • ⚠️ Risk: Low — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $90K-$160K. Portfolio play ($80K/mo combined) commands premium.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:

💰 Forecast Revenue / mo

MODEL
Revenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 12 of 12 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
Excellent rating (4.5★)METRIC
+$2,200
bugsREVIEW
−$1,800
5 starREVIEW
+$1,800
cancelledREVIEW
−$1,500
excellent appREVIEW
+$1,500
Low install base (3,470 ratings)METRIC
+$1,500
Mature app (10y old)METRIC
+$1,500
Multilingual (17 languages)METRIC
+$1,500
highly recommendREVIEW
+$1,400
slowREVIEW
−$1,200
too expensiveREVIEW
−$1,000
Ad-supported / freemiumMETRIC
+$600
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)

📈 Reviews Growth

LIVE
Cumulative review count from first BU snapshot. Each point = a tracked update.

⭐ Rating Trend

LIVE
Average rating evolution. Updates with each new review batch.

Profile & Insights

Everything we know — and don't — about this app and its company.

Identification

App name
Glykämischer Index. Diabetes.
Developer
App Holdings
Bundle ID
com.creamsoft.mygi
App Store URL
Open in App Store
Category
Education
Content rating
12+
Languages
BG, NL, EN, FI, FR, DE, HU, ID, IT, PL, PT, RU, ZH, ES, SV, ZH, TR

Company

Website
Not found
Tagline
Looking to sell your app or app portfolio?
Description
Not found
Founded
Not found
HQ / Address
Not found
Employees
Not found
Logo
Not found

Revenue

Verified revenue / mo
Not found
AI revenue estimate / mo
Not found
AI annual estimate
Not found
ML model estimate / mo
$421/mo
Top-grossing rank
🇩🇪#87 /99
All-time revenue
Not found
Pricing
Not found

Founder

Founder data not yet collected for this app.

Funding

Funding data not yet collected for this app.

Press & Links

Press & Links data not yet collected for this app.

Contacts & Socials

Contacts & Socials data not yet collected for this app.
📈Ratings growth3,470 ratings+23% lifetimeShow 3-year history estimate ▾Jun 2023Jan 2025Jun 2026
Tracked (58 weeks) Pre-tracking estimate (33 weeks) · model-based, ±5% noise · anchored to release date and current value
🗺️Geographic Distribution1 of 9 markets
🇩🇪
DE
Top-grossing rank: #87 / 99
Other markets
Outside top 100
in US, GB, DE, FR, JP, CA, AU, BR, IN
This app currently ranks in only one of the 9 markets we monitor. Niche or regional apps often launch this way before global rollout. Rankings update daily.
📊Category Rank Trajectory#87 now · best #80 · worst #99
Lower line = better rank · Estimate from ratings growth model · Lower position on chart = worse rank · Higher = top of chart
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.

📝 About this app

Are you tired of feeling like you're constantly battling against your own body? Do you wish there was a simple, easy-to-use tool that could help you take control of your health and prevent diabetes, fight weight gain, and control high glucose levels and blood pressure? Look no further than our innovative app.

Don't let diabetes, weight gain, or high blood pressure control your life any longer. Take charge of your health today by downloading our app and starting on the path towards a healthier, happier you. Our app is easy to use, intuitive, and designed with your needs in mind.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →
💾 50 MB🔞 12+📱 iOS 16.0+🔖 v4.3.12🔄 updated 0d ago🌐 BG, NL, EN, FI, FR +12📂 Education💰 Free
📅

What Worked™ · Development Pipeline

9 EVENTS TRACKED
Detected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-05
📈
Crossed 1,000 ratings — social-proof flywheel kicking in
2026-05
🔄
Monetization changed: freemium → free
2026-03
Rating ↑ 3.13 → 4.40 (improved 1.27★)
2026-03
📈
Crossed 500 ratings — social-proof flywheel kicking in
2018-10
📈
Crossed 100 ratings — social-proof flywheel kicking in
2017-03
📈
Crossed 50 ratings — social-proof flywheel kicking in
2016-05
📈
Crossed 10 ratings — social-proof flywheel kicking in
2016-04
Rating ↓ 5.00 → 4.43 (dropped 0.57★)
2016-03
🚀
First tracked snapshot — initial data captured
🔔

Track this app’s revenue

FREE
Get an email when revenue moves by your threshold. No spam, unsubscribe in one click.

📝 Description

95
BU Score · Transcendent
Full revenue analysis
Read the article-style breakdown for Glykämischer Index. Diabetes.: category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.
Read deep-dive →

More by App Holdings

View all →
📦 Portfolio summaryINDIE studio
27apps·$80K/mocombined
✓ Diversified — top app contributes 23%; risk spread across portfolio

Similar apps in Education

About this analysis
ZCAnalyzed by Zakhar Chumak · founder, bumetric·Full methodology·Medium confidence

Why medium confidence: 3,470 ratings · no founder-verified revenue (model estimate only).

Frequently Asked Questions

4 answers · auto-generated from this app's public data
How much does Glykämischer Index. Diabetes. make per month?
Based on our ML-calibrated revenue forecast, Glykämischer Index. Diabetes. earns approximately $421/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.
What apps are like Glykämischer Index. Diabetes.?
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes Glykämischer Index. Diabetes.?
Glykämischer Index. Diabetes. is published by App Holdings on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is Glykämischer Index. Diabetes.'s BU Score?
Glykämischer Index. Diabetes. has a BU Score of 63/100 (Solid). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.